MCC drug decision to be debated

South Africa's AIDS conference to debate Medicines Control Council rejection of AIDS prevention drug

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

South Africa's first national AIDS conference, which ends August 6, is to call an emergency session to debate a surprise decision by scientists to raise doubts about nevirapine, the one-shot treatment that is said to halve transmission of HIV during childbirth from mothers to their offspring.

Some 800,000 infants become infected with HIV each year worldwide, and 80,000 mothers in South Africa have already received the treatment, given as one dose at onset of labor. But South Africa's independent Medicines Control Council (MCC), composed of 10 committees with 146 members, last week announced that the Ugandan HIVNET012 study, on which claims for the efficacy and safety of nevirapine are based, "no longer meets regulatory requirements."

MCC had given the treatment provisional registration, but it announced on July 30 that "it is no longer valid for the MCC to continue to approve the use of nevirapine as a single agent" to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Robert Walgate

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide